Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Thermo Fisher Scientific (NY:TMO)

577.30 -2.64 (-0.45%)
Streaming Delayed Price Updated: 11:58 AM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
News headline image
2 S&P 500 Stocks Worth Investigating and 1 We Avoid
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Q3 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
News headline image
3 Mega-Cap Stocks with Warning Signs
Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works... 
Via StockStory
News headline image
OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy
From OlivePoint Capital
Via Business Wire
News headline image
3 Profitable Stocks Walking a Fine Line
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Economy
News headline image
Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health
New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend... 
Via MarketMinute
News headline image
Gapping S&P500 stocks in Thursday's session ↗
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value
SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has... 
Via MarketMinute
Topics Artificial Intelligence Economy Regulatory Compliance
News headline image
Institutions Love These 3 Companies, Should You As Well? ↗
Via MarketBeat
News headline image
These 3 Stocks Are Using Buybacks to Signal Market Confidence ↗
Via MarketBeat
News headline image
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' ↗
Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage. 
Via Benzinga
Topics ETFs
News headline image
Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗
With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation. 
Via Benzinga
Topics ETFs
News headline image
Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' ↗
Kimberly-Clark is still "oversold after the Kenvue announcement," Jenny Van Leeuwen Harrington says, citing its 5% dividend yield. 
Via Benzinga
News headline image
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Reinforces Investor Confidence with Latest Quarterly Dividend Declaration
Waltham, MA – November 6, 2025 – Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific instrumentation, laboratory services, and diagnostic solutions, today announced its latest... 
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
News headline image
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Thermo Fisher Scientific Declares Quarterly Dividend
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence
Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
How Is The Market Feeling About Thermo Fisher Scientific Inc? ↗
 
Via Benzinga
News headline image
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities ↗
Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and digital drug development capabilities. 
Via Benzinga
News headline image
Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal ↗
Thermo Fisher expects the acquisition to be immediately accretive to its adjusted operating margin. 
Via Stocktwits
News headline image
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
5 Revealing Analyst Questions From Thermo Fisher’s Q3 Earnings Call
Thermo Fisher's third quarter results drew a positive market response, with management attributing outperformance to robust momentum in bioproduction, analytical instruments, and clinical research... 
Via StockStory
Topics Earnings
News headline image
Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth ↗
Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth 
Via The Motley Fool
News headline image
If You Invested $1000 In Thermo Fisher Scientific Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
8 Analysts Have This To Say About Thermo Fisher Scientific ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.